Regulation of matrix metalloproteinases (MMPs) and their inhibitors (TIMPs) during mouse peri-implantation: Role of nitric oxide

Placenta

Volumn 25, Issue 4, 2004, Pages 243-252

  Zhang, X ^a   Wang, H M ^a   Lin, H Y ^a   Liu, G Y ^a,b   Li, Q L ^a   Zhu, C ^a  

^a INSTITUTE OF ZOOLOGY   (China)

^b HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE A; GELATINASE B; MATRIX METALLOPROTEINASE; MESSENGER RNA; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE DONOR; NITRIC OXIDE SYNTHASE INHIBITOR; NITROPRUSSIDE SODIUM; TISSUE INHIBITOR OF METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TISSUE INHIBITOR OF METALLOPROTEINASE 3;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EMBRYO; ENZYME ACTIVITY; ENZYME REGULATION; FEMALE; GENE EXPRESSION REGULATION; IN SITU HYBRIDIZATION; MALE; MOUSE; NIDATION; NONHUMAN; PREGNANCY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS INHIBITION; UTERUS HORN; ZYMOGRAPHY;

EID: 1942455308     PISSN: 01434004     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.placenta.2003.08.014     Document Type: Article

References (38)

1. Griffith OW, Stuehr DJ. Nitric oxide synthases: properties and catalytic mechanism. Annu Rev Physiol 1995;57:707-36.
2. Stuehr DJ, Marletta MA. Mammalian nitrate biosynthesis: mouse macrophages produce nitrite and nitrate in response to Escherichia coli lipopolysaccharide. Proc Natl Acad Sci U S A 1985; 82:7738-42.
3. Oswald IP, Eltoum I, Wynn TA, Schwartz B, Caspar P, Paulin D et al. Endothelial cells are activated by cytokine treatment to kill an intravascular parasite, Schistosoma mansoni, through the production of nitric oxide. Proc Natl Acad Sci U S A 1994;91:999-1003.
4. Reimers JI, Bjerre U, Mandrup-Poulsen T, Nerup J. Interleukin 1 beta induces diabetes and fever in normal rats by nitric oxide via induction of different nitric oxide synthases. Cytokine 1994;6:512-20.
5. Bredt DS, Snyder SH. Nitric oxide: a physiologic messenger molecule. Annu Rev Biochem 1994;63:175-95.
6. Moncada S, Palmer RM, Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991;43:109-42.
7. Shukovski L, Tsafriri A. The involvement of nitric oxide in the ovulatory process in the rat. Endocrinology 1994;135:2287-90.
8. Van Voorhis BJ, Dunn MS, Snyder GD, Weiner CP. Nitric oxide: an autocrine regulator of human granulosa-luteal cell steroidogenesis. Endocrinology 1994;135:1799-806.
9. Ota H, Igarashi S, Oyama N, Suzuki Y, Tanaka T. Optimal levels of nitric oxide are crucial for implantation in mice. Reprod Fertil Dev 1999; 11:183-8.
10. Novaro V, Gonzalez E, Jawerbaum A, Rettori V, Canteros G, Gimeno MF. Nitric oxide synthase regulation during embryonic implantation. Reprod Fertil Dev 1997;9:557-64.
11. Salamonsen LA. Role of proteases in implantation. Rev Reprod 1999; 4:11-22.
12. Fata JE, Ho AT, Leco KJ, Moorehead RA, Khokha R. Cellular turnover and extracellular matrix remodeling in female reproductive tissues: functions of metalloproteinases and their inhibitors. Cell Mol Life Sci 2000;57:77-95.
13. Waterhouse P, Denhardt DT, Khokha R. Temporal expression of tissue inhibitors of metalloproteinases in mouse reproductive tissues during gestation. Mol Reprod Dev 1993;35:219-26.
14. Murphy G, Cawston TE, Reynolds JJ. An inhibitor of collagenase from human amniotic fluid. Purification, characterization and action on metalloproteinases. Biochem J 1981;195:167-70.
15. Leco KJ, Edwards DR, Schultz GA. Tissue inhibitor of metalloproteinases-3 is the major metalloproteinase inhibitor in the decidualizing murine uterus. Mol Reprod Dev 1996;45:458-65.
16. Purcell TL, Given R, Chwalisz K, Garfield RE. Nitric oxide synthase distribution during implantation in the mouse. Mol Hum Reprod 1999; 5:467-75.
17. Saxena D, Purohit SB, Kumer GP, Laloraya M. Increased appearance of inducible nitric oxide synthase in the uterus and embryo at implantation. Nitric Oxide 2000;4:384-91.
18. Zhang X, Wang H, Lin H, Li Q, Liu D, Qian D et al. Regulation of embryo implantation by nitric oxide in mouse. Chinese Sci Bull 2002; 47:1461-5.
19. Psychoyos A. Hormonal control of ovoimplantation. Vitam Horm 1973, 31:201-56.
20. Olivier B, Walter W. A simplified in situ hybridization protocol using non-radioactively labeled probes to detect abundant and rare mRNAs on tissue sections. Biochemica 1998;1:10-6.
21. Wang HM, Li QL, Shao LJ, Zhu C. Expression of matrix metalloproteinase-2, -9, -14, and tissue inhibitors of metalloproteinase-1, -2, -3 in the endometrium and placenta of rhesus monkey (Macaca mulatta) during early pregnancy. Biol Reprod 2001;65:31-40.
22. Novaro V, Rettori V, Gonzalez ET, Jawerbaum A, Faletti A, Canteros G et al. Interaction between uterine PGE and PGF2 alpha production and the nitridergic system during embryonic implantation in the rat. Prostaglandins 1996;51:363-76.
23. 3 integrin in embryo implanta in the mouse. Chinese Sci Bull 2000; 45:2077-81.
24. Alexander CM, Hansell EJ, Behrendtsen O, Flannery ML, Kishnani NS, Hawkes SP et al. Expression and function of matrix metalloproteinases and their inhibitors at the maternal-embryonic boundary during mouse embryo implantation. Development 1996;122:1723-36.
25. Whiteside EJ, Jackson MM, Herington AC, Edwards DR, Harvey MB. Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-3 are key regulators of extracellular matrix degradation by mouse embryos. Biol Reprod 2001;64:1331-7.
26. Behrendtsen O, Alexander CM, Werb Z. Metalloproteinases mediate extracellular matrix degradation by cells from mouse blastocyst outgrowths. Development 1992;114:445-7.
27. Harvey MB, Leco KJ, Arcellana-Panlilio MY, Zhang X, Edwards DR, Schultz GA. Proteinase expression in early mouse embryos is regulated by leukaemia inhibitory factor and epidermal growth factor. Development 1995;121:1005-14.
28. Hurst PR, Palmay RD. Matrix metalloproteinases and their endogenous inhibitors during the implantation period in the rat uterus. Reprod Fertil Dev 1999;11:395-402.
29. Birkedal-Hansen H, Moore WG, Bodden MK, Windsor LJ, Birkedal-Hansen B, DeCarlo A et al. Matrix metalloproteinases: a review. Crit Rev Oral Biol Med 1993;4:197-250.
30. Orucevic A, Bechberger J, Green AM, Shapiro RA, Billiar TR, Lala PK. Nitric-oxide production by murine mammary adenocarcinoma cells promotes tumor-cell invasiveness. Int J Cancer 1999;81:889-96.
31. Duran-Reyes G, Gomez-Melendez MR, Morali-de la Brena G, Medo-Pichardo E, Medina-Navarro R, Hicks-Gomez JJ. Nitric oxide synthesis inhibition suppresses implantation and decreases cGMP concentration and protein peroxidation. Life Sci 1999;65:2259-68.
32. Edwards DR, Beaudry PP, Laing TD, Kowal V, Leco KJ, Leco PA et al. The roles of tissue inhibitors of metalloproteinases in tissue remodelling and cell growth. Int J Obes Relat Metab Disord 1996;3:S9.
33. Goldberg GI, Marmer BL, Grant GA, Eisen AZ, Wilhelm S, He CS. Human 72-kilodalton type IV collagenase forms a complex with a tissue inhibitor of metalloproteases designated TIMP-2. Proc Natl Acad Sci U S A 1989;86:8207-11.
34. Rajagopalan S, Meng XP, Ramasamy S, Harrison DG, Galis ZS. Reactive oxygen species produced by macrophage-derived foam cells regulate the activitY of vascular matrix metalloproteinases in vitro. Implications for atherosclerotic plaque stability. J Clin Invest 1996; 98:2572-9.
35. Owens MW, Milligan SA, Jourd'heuil D, Grisham MB. Effects of reactive metabolites of oxygen and nitrogen on gelatinase A activity. Am J Physiol 1997;273:L445-50.
36. Rogers PA. Early endometrial microvascular response during implantation in the rat. Reprod Fertil Dev 1992;4:261-4.
37. Ziche M, Morbidelli L. Nitric oxide and angiogenesis. J Neurooncol 2000;50:139-48.
38. Jackson CJ, Nguyen M. Human microvascular endothelial cells differ from macrovascular endothelial cells in their expression of matrix metalloproteinases. Int J Biochem Cell Biol 1997;29:1167-77.